WASHINGTON (Reuters) – Philip Morris International Inc should not be allowed to claim that its iQOS electronic tobacco device can reduce the risk of tobacco-related diseases compared with cigarettes, an advisory panel to the U.S. Food and Drug Administration said on Thursday.
Latest posts by Reuters News (see all)
- Almost 400 people winched from stricken cruise liner off Norway - March 24, 2019
- Thousands attend NZ vigil, rally to fight racism, remember Christchurch victims - March 24, 2019
- Rescue services prepare to tow stricken cruise ship off Norway to port - March 24, 2019